用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [药品] 包含 'Propranolol'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页308 条记录, 当前第1/31页。
公开号 公开日 申请号 申请日
1. CN102846546B 2014/3/19 CN20121130344 2012/4/27
专利标题:Can promote propranolol composite phospholipid carrier that percutaneous absorbs and preparation method thereof and application 法律状态


2. CN103622903A 2014/3/12 CN20131647695 2013/12/4
专利标题:Propranolol hydrochloride lipidosome gel and preparation method thereof 法律状态
专利权人


3. CN103635186A 2014/3/12 CN2012817339 2012/2/6
专利标题:The inhibitor that comprises the phosphatidic acid phosphohydrolase (pap) of d-propranolol and its analog, is used for the treatment of the cancer that depends on egf-r elisa (egfr), its carcinogenic variant and other members of erbb/her family separately 法律状态
专利权人


4. CN102871956B 2014/3/5 CN20121420731 2012/10/29
专利标题:A kind of propranolol hydrochloride gel for the treatment of infant superficial hemangioma 法律状态


5. CN103601646A 2014/2/26 CN20131512533 2013/10/28
专利标题:A kind of method for splitting of propranolol enantiomers 法律状态
专利权人


6. NZ594592A 2013/11/29 NZ20100594592 2010/4/12
专利标题:PAEDIATRIC SOLUTIONS COMPRISING A BETA-BLOCKER 法律状态
专利权人PIERRE FABRE DERMATOLOGIE;
594592 Disclosed herein is an aqueous ethyl alcohol free solution comprising a propranolol or pharmaceutically acceptable salts thereof, a non sugar type sweetener, such as saccharin sodium, and an aromatic preservative agent present in an amount of less 5 than 0.01w/V%


7. CN103385859A 2013/11/13 CN20121139274 2012/5/8
专利标题:Propranolol hydrochloride oral disintegrating tablet used for treating post-traumatic stress disorder, and preparation method thereof 法律状态


8. KR20130117681A 2013/10/28 KR20130041414 2013/4/16
专利标题:PHARMACEUTICAL COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING OBESITY, METABOLIC DISORDERS AND OSTEOPENIA ASSOCIATED WITH THE OBESITY COMPRISING BETA-BLOCKER 法律状态
PURPOSE: A pharmaceutical composition containing a beta-blocker is provided to prevent and treat obesity, metabolic diseases including diabetes, caused by obesity, osteopenia, and osteoporosis. CONSTITUTION: A pharmaceutical composition for preventing or treating obesity, metabolic disease caused by obesity, or osteopenia contains 0.001-50 wt% of a beta-blocker as an active ingredient. The beta-blocker is denoted by chemical formula 1. The beta-blocker is non-selective beta-blocker. The beta-blo...


9. CN102247326B 2013/10/23 CN20101173983 2010/5/17
专利标题:Oral chronopharmacologic drug delivery mini-pill preparation of propranolol and its salts 法律状态


10. RU2493832C2 2013/9/27 RU20100135514 2009/1/26
专利标题:Combinations of per oral medications, connected by coating 法律状态
专利权人Djuo-zhe;
FIELD: medicine pharmaceutics.SUBSTANCE: per oral pharmaceutical drug form in composition of which included are at least two medical substances in from of separately preliminarily formed pills. In claimed form medicinal substances from one side are together in hermetically in vivo water-soluble wrapping or coating and from the other side are separated in such a way that active agents of combined medicinal substances cannot contact with each other. At least one of medications is selected from the...



首页123456下页尾页308 条记录, 当前第1/31页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文